Latest news with #Maryland-based
CNBC
a day ago
- Business
- CNBC
With Trump tariffs in limbo, the uncertainty is 'killing' us, business owner says: 'We need to know what things are going to cost'
A U.S. trade court has ruled on President Trump's new round of import tariffs — covering thousands of products from nearly every country — calling them "unlawful." For now, though, while the administration pursues an appeal, those tariffs remain in place. In the meantime, business owners say they're left guessing how much they'll pay to import goods with trade rules that can change seemingly overnight. "The uncertainty surrounding tariffs is tough for our business, because we need to know what things are going to cost us three, six and 12 months down the road," says Michael Brey, owner of Hobby Works, a Maryland-based retail chain. The tariffs, announced April 2 under the International Emergency Economic Powers Act, added a 10% baseline tariff on most imported goods, a 20% tariff on Chinese imports and a 25% tariff on certain Canadian and Mexican goods that don't comply with the USMCA trade agreement. The U.S. Court of International Trade ruled Wednesday that the administration overstepped its executive authority by using IEEPA to impose these tariffs. Tariffs imposed under other trade laws — including 25% tariffs on steel, aluminum and auto imports — remain in effect. In response to the ruling, the Trump administration argued that IEEPA gives the president broad authority in foreign affairs and that overturning the tariffs would improperly narrow those powers. "I think it's a good ruling," Oliver Dunford tells CNBC Make It. Dunford is a senior attorney at Pacific Legal Foundation, which represents small businesses challenging the tariffs. "There's a good chance that it will be upheld." On Thursday, a federal appeals court paused the lower court's ruling, keeping tariffs in place while the government appeals. The next round of legal filings is due by June 9. Many small businesses say the shifting trade landscape creates headaches beyond the direct costs of the tariffs. Since March, Hobby Works has worked through thousands of price changes to reflect fluctuating import costs, Brey says. However, if the ruling is ultimately upheld, businesses could be eligible for refunds on tariffs already paid, though it could take months for any process to play out, says Dunford. Annie Park, co-owner of Sarah's Homemade Ice Cream in the Washington, D.C. area, says she's "relieved" by the ruling. One of her suppliers had already offered tariff credits before the appeals court's stay, she says. In the meantime, her expenses have increased and her business is making adjustments to its operations, she says, such as discontinuing certain flavors due to higher costs. Even if these particular tariffs are struck down, the White House has other tools it could use to impose new ones, including sections of U.S. trade law that allow tariffs on national security or retaliatory grounds, Goldman Sachs analysts have noted. The administration could try to take the current case to the U.S. Supreme Court if it loses on appeal, which would extend the legal fight even further. For now, the uncertainty is likely to continue as the appeal moves forward and the administration weighs its next steps. "The volatility and uncertainty is making stock market speculators rich, but it is killing the people who actually have to operate the businesses," says Brey. ,
Yahoo
a day ago
- General
- Yahoo
Smoking marijuana and eating cannabis gummies both linked to dangerous health risk, study finds
Long-term cannabis use in any form has been linked to a greater risk of heart disease. In a new study, researchers at UC San Francisco determined that eating edible cannabis, such as gummies, has the same impact on cardiovascular risk as smoking marijuana. The risk stems from reduced blood vessel function, according to the study, which was published in JAMA Cardiology on May 28. Heavy Cannabis Use Could Pose This Threat To The Brain The study included 55 people between 18 and 50 years of age who were "outwardly healthy." The participants were divided into three groups: those who regularly smoked marijuana, those who ate edibles containing THC (tetrahydrocannabinol), and those who didn't use cannabis, according to a UCSF press release. Read On The Fox News App The cannabis users had been consuming the substance at least three times weekly for at least one year. On average, the smokers had the habit for 10 years, while those consuming edibles had been doing so for five years, the release noted. In September 2024, the participants underwent testing to determine how well their blood vessels functioned and whether the cells lining the blood vessels were affected. Dementia Risk Connected To Cannabis-related Hospital Visits, Says Study All cannabis users were found to have "decreased vascular function," comparable to those who smoke tobacco. Their blood vessel function was roughly half compared to those who did not use cannabis. This side effect has been linked to a higher risk of heart attack, high blood pressure and other cardiovascular conditions, the researchers noted. The participants who smoked marijuana were also found to have changes in their blood serum that harmed cells lining their blood vessels and lymphatic vessels, an effect that was not seen in those who ate edible cannabis. The researchers noted that while smoking marijuana and consuming edibles both affect vascular function, they likely do so for different reasons. Shingles Vaccine Has Unexpected Effect On Heart Health "Chronic cannabis smoking and THC ingestion were associated with endothelial dysfunction [impaired functioning of the endothelial cells lining the inside of blood vessels] similar to that observed in tobacco smokers, although apparently occurring via distinct mechanisms," the researchers wrote. "This study enhances the understanding of the potential risks to vascular health linked to cannabis use and provides more evidence that cannabis use is not benign." Dr. Bradley Serwer, a Maryland-based cardiologist and chief medical officer at VitalSolution, an Ingenovis Health company that offers cardiovascular and anesthesiology services to hospitals nationwide, said he was not surprised by the study's findings. "We have known that the chronic use of THC-containing compounds can have negative health consequences — this study just reaffirms those prior studies," Serwer, who was not involved in the UCSF research, told Fox News Digital. The study did have some limitations. "Variability in cannabis strains complicates standardization," the researchers wrote. "Self-reported cannabis use may introduce recall bias; thus, participants were queried at multiple points: in the online survey, at the eligibility interview and before each visit." It was also challenging to determine whether blood vessel function could have also been affected by lifestyle factors like stress, caffeine and secondhand smoke exposure, they noted. Serwer pointed out that this was a "very small" study of only 55 people, all living in the San Francisco Bay area. "The study did not allow for variability in the different strains of cannabis, and they used a self-reporting survey, which can be under- or over-reported," he told Fox News Digital. "They looked for physiologic endpoints and not hard endpoints, such as heart attacks, strokes or death. We have to infer that the physiologic endpoints would result in cardiovascular events." Click Here To Sign Up For Our Health Newsletter The cardiologist said he agreed, however, with the conclusion that cannabis use is "not benign." "Chronic use does have potential cardiovascular risks," he warned. "There are therapeutic uses of cannabis, and the decision to use or avoid it should be made with all benefits and risks in mind." In general, Serwer said he cautions all of his patients to avoid any unnecessary cardiac risks. "As clinicians, we must weigh the benefits and the risks of a medicine/drug or intervention," he said. "If the risks outweigh the benefits, it should be avoided." For more Health articles, visit The study was funded mainly by the National Institute on Drug Abuse; the California Department of Cannabis Control; the California Tobacco-Related Disease Program; the National Heart, Lung, and Blood Institute; and the FDA Center for Tobacco Products. Fox News Digital reached out to cannabis industry organizations requesting article source: Smoking marijuana and eating cannabis gummies both linked to dangerous health risk, study finds
Epoch Times
2 days ago
- Health
- Epoch Times
Multistate Salmonella Outbreak: Cucumber Products Recalled, 26 People Infected
Multiple cucumber products sold in several states are being recalled because of potential salmonella contamination amid an ongoing multistate outbreak. Maryland-based The Coastal Companies is withdrawing 17 products containing cucumbers from the market, including salsas and salads, according to a May 27 recall
Yahoo
2 days ago
- Business
- Yahoo
William Blair Starts Centrus Energy With Outperform, Cites Nuclear Fuel Leadership
William Blair analyst Jed Dorsheimer initiated coverage of Centrus Energy Corp. (NYSE:LEU) on May 28 with an Outperform rating and no price target. The analyst emphasized Centrus Energy's distinct market position as the sole American-owned uranium enricher, which provides the company with advantages in terms of technology and national security. Photo by Frédéric Paulussen on Unsplash Centrus's shift from a foreign nuclear fuel broker to a manufacturer and supplier should enable the company to capture a sizable portion of the market. According to Dorsheimer, Centrus Energy Corp. (NYSE:LEU) is expected to play a significant role in supplying the United States' commercial nuclear fleet with low-enriched uranium and high-assay low-enriched uranium. The analyst also highlighted the company's contribution to reducing U.S. dependence on Russian enrichment capabilities, projecting a $15 billion total addressable market (TAM) that will be fueled by a 13-fold growth in demand for separative work units (SWU) by 2050. Centrus Energy Corp. (NYSE:LEU) is a Maryland-based supplier of nuclear fuel components and services that operates under two business categories: Low-Enriched Uranium and Technical Solutions. While we acknowledge the potential of LEU to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than LEU and that has 100x upside potential, check out our report about the cheapest AI stock. Read More: and Disclosure: None. Sign in to access your portfolio
Yahoo
2 days ago
- Business
- Yahoo
CMS AI Implementer Skyward Launches SkyAI Hub, Pioneering Government-Ready Agentic AI to Boost Federal Efficiency
WASHINGTON, May 29, 2025 (GLOBE NEWSWIRE) -- Skyward, a leader in AI infrastructure for the public sector, today announced the launch of its SkyAI Hub, a first-of-its-kind ecosystem of intelligent agents designed to transform government operations. In partnership with the Centers for Medicare & Medicaid Services (CMS), Skyward is deploying AI agents that are delivering significant operational cost savings across critical federal services. The SkyAI Hub provides federal agencies with secure, modular, and audit-ready AI Control Center and Agents that automate complex workflows, reduce manual workload, and improve service delivery at scale. Through its pilot integration with CMS, Skyward's AI assistants have demonstrated a reduction in administrative processing time by over 70%, directly translating into millions of dollars in cost savings and enhanced efficiency. 'This partnership marks a pivotal step toward modernizing public service through AI,' said Dmitry Yun, CEO of Skyward. 'The Skyward AI Hub is not just about automation—it's about rethinking how the government works for the people by deploying intelligent systems that are fast, compliant, and cost-effective.' SkyAI agents are purpose-built to meet federal compliance and security standards while offering seamless integration with existing government systems. The marketplace offers a growing catalog of AI modules covering procurement, claims processing, research and data analytics, fraud detection, compliance auditing, and real-time customer support. 'We're proving that ethical, scalable AI can solve real administrative pain points and generate tangible value for taxpayers not only at CMS but across the Federal government,' added Vitaly Baklikov, CTO of SkywardFounded in 2013, Skyward is a Maryland-based digital services company and trusted federal partner specializing in AI/ML, Agile DevSecOps, Data Science, and Customer Experience. As an 8(a) small business and proud member of the Digital Services Coalition, Skyward is committed to delivering secure, scalable, and user-centered technology solutions that serve the American people. For over a decade, Skyward has worked shoulder-to-shoulder with U.S. federal agencies to modernize mission-critical systems and improve public service delivery. Our clients include the Centers for Medicare & Medicaid Services (CMS), the U.S. Small Business Administration, Department of Transportation and the Department of Homeland Security.. With a deep focus on outcomes, transparency, and agility, Skyward is redefining how the government leverages next-generation technology to operate smarter, faster, and more cost-effectively. Contact:-Ksenia Kapoor PR Lead kkapoor@ This is a paid post and is provided by Skyward. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. This content is for informational purposes only and should not be considered financial, investment, or business advice. All investments carry inherent risks, including the potential loss of capital. Readers are strongly encouraged to conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Neither the media platform nor the publisher shall be held responsible for any inaccuracies, misrepresentations, or financial losses resulting from the use or reliance on the information in this press release. Speculate only with funds you can afford to lose. In the event of any legal claims or concerns regarding this article, we accept no liability or responsibility. Legal Disclaimer: This media platform provides the content of this article on an "as-is" basis, without warranties or representations of any kind, express or implied. We assume no responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained herein. Any complaints, copyright issues, or inquiries regarding this article should be directed to the content provider listed above. Photos accompanying this announcement are available at:
